NanJing Pharmaceutical Company Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 39,817.363 million compared to CNY 37,155.742 million a year ago. Operating income was CNY 676.260 million compared to CNY 528.723 million a year ago. Net income was CNY 376.413 million compared to CNY 346.920 million a year ago. Basic earnings per share from continuing operations was CNY 0.361 compared to CNY 0.333 a year ago.